ZANVASTRO™ (ZILGANERSEN) APPROVED BY THE FDA AS THE FIRST AND ONLY DISEASE MODIFYING TREATMENT FOR ALEXANDER DISEASE (AXD) IN PEDIATRIC AND ADULT PATIENTS

Reuters · 1d ago

Please log in to view news